Rhythm Pharma's drug for rare obesity meets late-stage trial goalR
Continue reading...
Rhythm Pharma’s drug for rare obesity meets late-stage trial goal
Rhythm Pharma's drug for rare obesity meets late-stage trial goal
Rhythm Pharmaceuticals (RYTM.O), opens new tab said on Monday its drug Imcivree notably reduced weight in patients...